Optimi

Optimi company information, Employees & Contact Information

Explore related pages

Related company profiles:

Optimi Health exists to grow psychedelic science and medicine as an industry-leading supplier of natural, pharmaceutical-grade psilocybin and synthetic psychedelic compounds. Our Purpose is to produce scalable, natural mushroom formulations and other psychedelics for transformational human experiences. Our Goal is to be the number one trusted, compassionate supplier of safe, natural EU-GMP-grade psilocybin and synthetic psychedelics across the world. Our Promise is to make possible a future whereby psychedelic alternatives aid a wide variety of mental health conditions.

Company Details

Employees
19
Founded
-
Address
Princeton, British Columbia, Ca
Industry
Wellness And Fitness Services
NAICS
Fitness and Recreational Sports Centers
Keywords
Princeton.
HQ
Princeton, British Columbia
Looking for a particular Optimi employee's phone or email?

Optimi Questions

News

Optimi Health Provides Corporate Update - Newsfile

Optimi Health Provides Corporate Update Newsfile

Optimi Health's Psilocybin Capsules Selected for Medibank Insurance Program - Investing News Network

Optimi Health's Psilocybin Capsules Selected for Medibank Insurance Program Investing News Network

Optimi Health (OTCQX: OPTHF) earns GMP-compliant rating after Health Canada DEL inspection - Stock Titan

Optimi Health (OTCQX: OPTHF) earns GMP-compliant rating after Health Canada DEL inspection Stock Titan

$10M Medibank psychotherapy program selects Optimi's 5mg psilocybin capsules for TRD - Stock Titan

$10M Medibank psychotherapy program selects Optimi's 5mg psilocybin capsules for TRD Stock Titan

Optimi Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering - Newsfile

Optimi Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering Newsfile

Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression - Investing News Network

Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression Investing News Network

Optimi Health Completes Largest MDMA Capsule Batch to Date, Expands Stability Program - Yahoo Finance

Optimi Health Completes Largest MDMA Capsule Batch to Date, Expands Stability Program Yahoo Finance

Canadian MDMA & Psilocybin Manufacturer Optimi Health Aims for Major U.S. Market with Nasdaq IPO Filing - Stock Titan

Canadian MDMA & Psilocybin Manufacturer Optimi Health Aims for Major U.S. Market with Nasdaq IPO Filing Stock Titan

Optimi Health Announces $3.45 Million Convertible Financing and Extension of Secured Term Loan - Newsfile

Optimi Health Announces $3.45 Million Convertible Financing and Extension of Secured Term Loan Newsfile

Optimi Health Announces Receipt of Purported Termination Notice - Psychedelic Alpha

Optimi Health Announces Receipt of Purported Termination Notice Psychedelic Alpha

Optimi Announces Closing of First Tranche of Non-Brokered Private Placement - GlobeNewswire

Optimi Announces Closing of First Tranche of Non-Brokered Private Placement GlobeNewswire

Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder - Yahoo Finance

Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder Yahoo Finance

Optimi Health Provides Corporate Update - Newsfile

Optimi Health Provides Corporate Update Newsfile

Optimi Health Announces CAD$1.2 Million GMP Psilocybin Supply Agreement for Clinical Research and Development - Psychedelic Alpha

Optimi Health Announces CAD$1.2 Million GMP Psilocybin Supply Agreement for Clinical Research and Development Psychedelic Alpha

Optimi Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering - Investing News Network

Optimi Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering Investing News Network

Optimi Health Obtains U.S. FDA Drug Establishment Registration - Newsfile

Optimi Health Obtains U.S. FDA Drug Establishment Registration Newsfile

Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida Global - Psychedelic Alpha

Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida Global Psychedelic Alpha

Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent - Psychedelic Alpha

Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent Psychedelic Alpha

Optimi Health Completes Second MDMA Shipment to Australia and Expands 2025 Production Forecast to Support Over 5,000 Patients Globally - Newsfile

Optimi Health Completes Second MDMA Shipment to Australia and Expands 2025 Production Forecast to Support Over 5,000 Patients Globally Newsfile

Optimi Health Announces Leadership Transition - Newsfile

Optimi Health Announces Leadership Transition Newsfile

Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP Capsules - Yahoo Finance

Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP Capsules Yahoo Finance

Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program - Psychedelic Alpha

Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program Psychedelic Alpha

Optimi Health Signs Psilocybin Supply Agreement With Halucenex Life Sciences Inc. - Investing News Network

Optimi Health Signs Psilocybin Supply Agreement With Halucenex Life Sciences Inc. Investing News Network

Optimi Health Finalizes Psilocybin Supply Agreement With Bloom Psychedelic Therapy And Research Centre - Investing News Network

Optimi Health Finalizes Psilocybin Supply Agreement With Bloom Psychedelic Therapy And Research Centre Investing News Network

Optimi Health Receives Health Canada NPN Product Licenses in Preparation for Q2 Sales Launch - Psychedelic Alpha

Optimi Health Receives Health Canada NPN Product Licenses in Preparation for Q2 Sales Launch Psychedelic Alpha

Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreements for Functional Mushroom Supplements and Appoints Chief Financial Officer to its Board of Directors - Investing News Network

Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreements for Functional Mushroom Supplements and Appoints Chief Financial Officer to its Board of Directors Investing News Network

Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients - Psychedelic Alpha

Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients Psychedelic Alpha

Optimi Health Completes First International Shipment of MDMA to Israel and Secures CBSA Exporters Authorization ID - Newsfile

Optimi Health Completes First International Shipment of MDMA to Israel and Secures CBSA Exporters Authorization ID Newsfile

Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History - Psychedelic Alpha

Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History Psychedelic Alpha

Optimi Health Announces Canadian Retail and E-Commerce - GlobeNewswire

Optimi Health Announces Canadian Retail and E-Commerce GlobeNewswire

Open For Business: Optimi Completes First Grow of Psilocybin Mushrooms and Introduces Head of Cultivation - Investing News Network

Open For Business: Optimi Completes First Grow of Psilocybin Mushrooms and Introduces Head of Cultivation Investing News Network

Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and MDMA Clinical Trial Application to Health Canada - Investing News Network

Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and MDMA Clinical Trial Application to Health Canada Investing News Network

Optimi Health Opens Canada's Largest GMP-Grade Licensed Psilocybin Cultivation Facility - Investing News Network

Optimi Health Opens Canada's Largest GMP-Grade Licensed Psilocybin Cultivation Facility Investing News Network

Alberta Puts Patients First By Regulating Psychedelic Therapy: Optimi Health - Investing News Network

Alberta Puts Patients First By Regulating Psychedelic Therapy: Optimi Health Investing News Network

Optimi Health Large Scale Multi-Purpose Mushroom Facility Advances Towards Completion and Licensing - GlobeNewswire

Optimi Health Large Scale Multi-Purpose Mushroom Facility Advances Towards Completion and Licensing GlobeNewswire

Optimi Health Announces Closing of Strategic Non-Brokered Private Placement - Investing News Network

Optimi Health Announces Closing of Strategic Non-Brokered Private Placement Investing News Network

Optimi Health Awarded Drug Establishment Licence From Health Canada - PR Newswire Canada

Optimi Health Awarded Drug Establishment Licence From Health Canada PR Newswire Canada

Top Optimi Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant